The Myeloma Crowd
Research Initiative (MCRI)

  • OPTIMIZING MYELOMA CARE

To get our best possible outcomes, patients need to receive the right treatment at the right time for their unique myeloma. We are funding projects to find the best possible personalized treatments for each patient.

The Myeloma Crowd Research Initiative (MCRI) is a new approach to funding cancer research; combining the skill and knowledge of leading myeloma specialists with the patient perspective and supportive patient social communities to select and fund promising research projects in myeloma. Our goal is to find and fund a cure for multiple myeloma.

STAGES

FUNDRAISING

Our goal is to provide $500,00 in funding to several research projects to identify optimal therapies for individual patients.

$53,275 of $500,000 Raised

Please help us fully fund these promising research projects by donating today.

ADVISORY BOARDS

Scientific Advisory Board

C. Ola Landgren, MD, PhD
C. Ola Landgren, MD, PhDChief, Myeloma Service at Memorial Sloan Kettering Cancer Center
Irene Ghobrial, MD, PhD
Irene Ghobrial, MD, PhDDirector, Michele & Stephen Kirsch Laboratory at Dana Farber Cancer Institute
Guido Tricot, MD, PhD
Guido Tricot, MD, PhDDirector, Bone Marrow Transplant and Myeloma Program at Holden Comprehensive Cancer Center, U of Iowa